Clinics across Florida, New Je


Teva Pharmaceuticals, the National Association of Free and Charitable Clinics (NAFC), and Direct Relief today announced — as part of a two-year, $2 million commitment — awarding $825,000 in grants to 11 free, charitable mental health clinics across Florida, New Jersey and California.

The winners were selected for their innovative and practical approaches to mental health care, which include efforts to expand access to health care for underserved and vulnerable patients with mental and behavioral health issues, by emphasizing the focus on depression and anxiety.

“The free, charitable clinics chosen for this initiative are already providing exceptional care in their communities, and this funding, generously provided by Teva, will allow them to do even more, expanding lifesaving mental health care to those who need it. most needed. said Thomas Tighe, CEO and President of Direct Relief.

In addition to funding, Teva makes a broad portfolio of generic mental health medicines available on a charitable basis.

“Teva is proud to partner with Direct Relief and the National Association of Free and Charitable Clinics on Community routes: access to mental health care, a new health equity initiative to expand access to health services for underserved populations,added Dr. Sven Dethlefs, executive vice president, North America Commercial. “At Teva, we know how critical it is to enable access to medicines that help improve people’s lives and we’re excited to see how these local clinics create or expand the necessary programs that have a real impact on people’s lives. patients. »

Anxiety and depressive disorders affect more than 40 million adults in the United States each year. Additionally, 84% of physicians reported an increase in new diagnoses of mental health conditions since the start of the pandemic, particularly among racial and ethnic minorities and low-income households, according to a recent national survey conducted by the Morehouse. School of Medicine and Teva Pharmaceuticals.

“Through this program, clinics will be able to improve and expand access to crucial mental health services for their communities,” said Nicole Lamoureux, President and CEO of the NAFC. “NAFC is grateful that Direct Relief and Teva Pharmaceuticals not only recognize the barriers to communities of care that communities of care often face and the importance of mental health care, but are also taking steps to join in the NAFC and support our clinics in the field to provide solutions and better access to care.

The 2022 winners are:


  • University of Florida Mobile Outreach in Gainesville, Florida – Creates and delivers an evidence-based mental health wellness program that is easily accessible to underserved populations through trusted community members through a mobile outreach model.
  • Grace Medical Home in Orlando, Florida – Expands an existing program that proactively identifies trauma and delivers individualized interventions through an integrated, comprehensive, and multidisciplinary approach to improve health outcomes.
  • Talbot House Ministries of Lakeland, Inc., in Lakeland, Florida – Supports pharmacy-provided medication reconciliation services, outreach and event coordination, and homeless encampment outreach to connect to clinical services and referrals for mental health care, patient transport and education.


  • Cape Volunteers in Medicine at Cape May Court House, New Jersey – Improve mental and behavioral health access and treatment among at-risk populations by expanding screenings for depression and anxiety. The funding will also support community events to identify the mental and physical needs of community members.
  • Bergen Volunteer Medical Initiative, Inc., in Hackensack, New Jersey – Increases capacity and fills a much-needed gap in care for Spanish-speaking patients with depression and anxiety with the support of a bilingual mental health practitioner.
  • Parker Family Health Center in Red Bank, New Jersey – Supports a collaboration with the Monmouth County Mental Health Association, which sees a bilingual therapist offer weekly counseling and the creation of mental health education to share at live community events, virtually and digitally.


  • Samaritan House in San Mateo, California Samaritan House in San Mateo, CA – Expands existing mental health services to include an internship program for students pursuing graduate studies in marriage and family therapy or social work. The program also aims to strengthen collaboration with community organizations that provide more specialized care, develop educational resources and offer comprehensive services to patients suffering from depression and anxiety.
  • Symba Center in Apple Valley, California – Supports successful trauma-informed mental and behavioral health care in a homeless shelter.
  • Westminster Free Clinic in Thousand Oaks, CA – Offers a range of mental health services, including one-on-one and peer support, and a training program that helps parents identify early signs of mental health issues.
  • Lestonnac Free Clinic in Orange, CA – Supports a licensed clinical social worker and programs to provide care through a trauma-informed lens, who will also supervise and mentor interns from local colleges and universities.
  • Savie Health in Lompoc, CA – Provides culturally appropriate resources and referrals to help patients overcome barriers to mental health care through bilingual community health workers.

About Direct Relief

A humanitarian organization committed to improving the health and lives of those affected by poverty and emergencies, Direct Relief provides vital medical resources in the United States and around the world to communities in need, without regard to politics, religion or ability to pay. For more information, visit

About the National Association of Free and Charitable Clinics

The National Association of Free and Charitable Clinics (NAFC) is the only 501c(3) nonprofit organization whose mission is uniquely focused on the issues and needs of the medically underserved across the country and the more 1,400 free and charitable clinics serving them. NAFC has earned the Platinum Seal of Transparency from GuideStar and a 4-star rating from Charity Navigator. Founded in 2001 and based near Washington, D.C., NAFC works to ensure that the medically underserved have access to affordable, quality health care and strives to be a national voice promoting health care quality for all. For more information on the ANCA, please visit

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic, biosimilar and specialty medicines with a portfolio of over 3,500 products in nearly every therapeutic area. Approximately 200 million people worldwide take a Teva medicine every day and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations that support our growing portfolio of specialty and biopharmaceutical products. Learn more about


This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on the current beliefs and expectations of the management of Teva and are subject to substantial risks and uncertainties, known and unknown, that could affect our future. results, performance or achievements differ materially from those expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to impact our social, economic, environmental and governance strategies and objectives and execute them effectively; our ability to meet the targets set out in our senior sustainability notes and other sustainability financing instruments that we may issue; and the impact of ESG issues on our business; our ability to successfully compete in the marketplace, including: that we are highly dependent on our generic products; our substantial indebtedness; our business and operations generally, including: uncertainty regarding the COVID-19 pandemic and governmental and societal responses to it, costs and delays resulting from the extensive pharmaceutical regulations to which we are subject or delays in government processing time due to travel and work restrictions caused by the COVID-19 pandemic, the effects of healthcare regulatory reforms and reductions in pharmaceutical pricing, reimbursement and coverage; compliance, regulatory and litigation matters, including: failure to comply with complex legal and regulatory environments, increased legal and regulatory action in relation to public concerns about opioid drug abuse and our ability to reach final resolution of remaining opioid-related disputes; the scrutiny of competition and pricing authorities around the world, including our ability to successfully defend ourselves against criminal charges by the United States Department of Justice for violation of the Sherman Act; potential liability for patent infringement; product liability claims; failure to meet complex Medicare and Medicaid reporting and payment obligations; and compliance with anti-corruption sanctions and trade control laws; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the second quarter of 2022 and our Annual Report on Form 10-K for the year ended December 31, 2021, including in the sections captioned “Factors of Risk” and “Risk Factors-Looking Statements” and in our other reports that we file with the United States Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to place undue reliance on these forward-looking statements.

See the source version on


Comments are closed.